Tekmira to produce Ebola treatment for U.S. Defense

Nov 6 (Reuters) - Canada's Tekmira Pharmaceuticals Corp has agreed to make 500 courses of its experimental treatment for Ebola for the U.S. Department of Defense, the company said on Thursday.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.